• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COX-2 和 PGE2 依赖性乳腺癌免疫调节。

COX-2 and PGE2-dependent immunomodulation in breast cancer.

机构信息

Department of Pharmacology, University of Pennsylvania, Institute for Translational Medicine and Therapeutics, Philadelphia, PA, USA.

出版信息

Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):14-20. doi: 10.1016/j.prostaglandins.2011.08.005. Epub 2011 Aug 31.

DOI:10.1016/j.prostaglandins.2011.08.005
PMID:21907301
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4031099/
Abstract

COX-derived prostanoids play multiple roles in inflammation and cancer. This review highlights research examining COX-2 and PGE(2)-dependent regulation of immune cell polarization and function within the tumor microenvironment, particularly as it pertains to breast cancer. Appreciating PGE(2)-mediated immunomodulation is important in understanding how tumors evade immune surveillance by re-educating infiltrating inflammatory and immune cells to support tumorigenesis. Elucidation of the multiple and complex influences exerted by tumor stromal components may lead to targeted therapies in breast and other cancers that restrain microenvironmental permissiveness and maintain natural defenses against malignancies.

摘要

COX 衍生的前列腺素在炎症和癌症中发挥多种作用。本综述重点介绍了研究 COX-2 和 PGE(2)依赖性调节肿瘤微环境中免疫细胞极化和功能的研究,特别是与乳腺癌有关的研究。了解 PGE(2)介导的免疫调节对于理解肿瘤如何通过重新教育浸润性炎症和免疫细胞来支持肿瘤发生从而逃避免疫监视非常重要。阐明肿瘤基质成分施加的多种复杂影响可能会导致针对乳腺癌和其他癌症的靶向治疗,这些治疗可以限制微环境的许可并维持对恶性肿瘤的天然防御。

相似文献

1
COX-2 and PGE2-dependent immunomodulation in breast cancer.COX-2 和 PGE2 依赖性乳腺癌免疫调节。
Prostaglandins Other Lipid Mediat. 2011 Nov;96(1-4):14-20. doi: 10.1016/j.prostaglandins.2011.08.005. Epub 2011 Aug 31.
2
Mammary carcinoma cell derived cyclooxygenase 2 suppresses tumor immune surveillance by enhancing intratumoral immune checkpoint activity.乳腺癌细胞衍生的环氧化酶2通过增强肿瘤内免疫检查点活性来抑制肿瘤免疫监视。
Breast Cancer Res. 2013;15(5):R75. doi: 10.1186/bcr3469.
3
Progesterone promotes immunomodulation and tumor development in the murine mammary gland.孕酮促进小鼠乳腺的免疫调节和肿瘤发展。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-001710.
4
Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets.炎症性肠病和结直肠癌中的调节性T细胞亚群:特征、作用及治疗靶点。
J Gastroenterol Hepatol. 2016 Aug;31(8):1393-404. doi: 10.1111/jgh.13342.
5
The role of PGE2-associated inflammatory responses in gastric cancer development.前列腺素 E2 相关炎症反应在胃癌发展中的作用。
Semin Immunopathol. 2013 Mar;35(2):139-50. doi: 10.1007/s00281-012-0353-5. Epub 2012 Oct 11.
6
Advancing Immunotherapy in Metastatic Breast Cancer.转移性乳腺癌的免疫治疗进展
Curr Treat Options Oncol. 2017 Jun;18(6):35. doi: 10.1007/s11864-017-0478-9.
7
The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes.乳腺癌中异质性免疫微环境受缺氧相关基因影响。
Immunobiology. 2014 Feb;219(2):158-65. doi: 10.1016/j.imbio.2013.09.003. Epub 2013 Sep 8.
8
Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer.靶向白细胞介素(IL)-17A可抑制肿瘤细胞中PDL1的表达,并在雌激素受体阴性的小鼠乳腺癌模型中诱导抗癌免疫。
Oncotarget. 2017 Jan 31;8(5):7614-7624. doi: 10.18632/oncotarget.13819.
9
Induction of DNMT3B by PGE2 and IL6 at Distant Metastatic Sites Promotes Epigenetic Modification and Breast Cancer Colonization.前列腺素 E2 和白细胞介素 6 在远处转移部位诱导 DNMT3B 的表达,促进了表观遗传修饰和乳腺癌的定植。
Cancer Res. 2020 Jun 15;80(12):2612-2627. doi: 10.1158/0008-5472.CAN-19-3339. Epub 2020 Apr 7.
10
Constitutive IDO1 Expression in Human Tumors Is Driven by Cyclooxygenase-2 and Mediates Intrinsic Immune Resistance.人肿瘤中组成性 IDO1 表达受环氧化酶-2 驱动,并介导固有免疫抵抗。
Cancer Immunol Res. 2017 Aug;5(8):695-709. doi: 10.1158/2326-6066.CIR-16-0400. Epub 2017 Jul 21.

引用本文的文献

1
Soft matrix promotes immunosuppression in tumor-resident immune cells via COX-FGF2 signaling.软基质通过COX-FGF2信号通路促进肿瘤驻留免疫细胞中的免疫抑制。
Nat Commun. 2025 May 27;16(1):4908. doi: 10.1038/s41467-025-60092-x.
2
Aspirin in Cancer Therapy: Pharmacology and Nanotechnology Advances.阿司匹林在癌症治疗中的应用:药理学与纳米技术进展
Int J Nanomedicine. 2025 Feb 23;20:2327-2365. doi: 10.2147/IJN.S505636. eCollection 2025.
3
Targeting CD200 in Breast Cancer: Opportunities and Challenges in Immunotherapeutic Strategies.靶向乳腺癌中的CD200:免疫治疗策略中的机遇与挑战
Int J Mol Sci. 2024 Dec 26;26(1):115. doi: 10.3390/ijms26010115.
4
Treatment of cancer-associated fibroblast-like cells with celecoxib enhances the anti-cancer T helper 1/Treg responses in breast cancer.用塞来昔布治疗癌症相关成纤维样细胞可增强乳腺癌中抗癌辅助性T细胞1/调节性T细胞反应。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May;398(5):6099-6112. doi: 10.1007/s00210-024-03641-3. Epub 2024 Dec 9.
5
Exploring the contrasts: in-depth analysis of human and canine mammary tumors - discoveries at the frontier.探索差异:对人类和犬类乳腺肿瘤的深入分析——前沿发现
Med Pharm Rep. 2024 Apr;97(2):132-142. doi: 10.15386/mpr-2733. Epub 2024 Apr 25.
6
Advances in PGD2/PTGDR2 signaling pathway in tumors: A review.肿瘤中 PGD2/PTGDR2 信号通路的研究进展:综述。
Biomol Biomed. 2024 Sep 6;24(5):1055-1067. doi: 10.17305/bb.2024.10485.
7
Unveiling Alterations of Epigenetic Modifications and Chromatin Architecture Leading to Lipid Metabolic Reprogramming during the Evolutionary Trastuzumab Adaptation of HER2-Positive Breast Cancer.揭示表观遗传修饰和染色质结构的改变,导致 HER2 阳性乳腺癌在进化性曲妥珠单抗适应过程中的脂质代谢重编程。
Adv Sci (Weinh). 2024 May;11(18):e2309424. doi: 10.1002/advs.202309424. Epub 2024 Mar 9.
8
Melanoma Cells Inhibit iNKT Cell Functions via PGE2 and IDO1.黑色素瘤细胞通过PGE2和IDO1抑制iNKT细胞功能。
Cancers (Basel). 2023 Jul 5;15(13):3498. doi: 10.3390/cancers15133498.
9
Pleiotropic effects of the COX-2/PGE2 axis in the glioblastoma tumor microenvironment.环氧合酶-2/前列腺素E2轴在胶质母细胞瘤肿瘤微环境中的多效性作用
Front Oncol. 2023 Jan 26;12:1116014. doi: 10.3389/fonc.2022.1116014. eCollection 2022.
10
The Role of Thymoquinone in Inflammatory Response in Chronic Diseases.姜黄素在慢性疾病炎症反应中的作用。
Int J Mol Sci. 2022 Sep 6;23(18):10246. doi: 10.3390/ijms231810246.

本文引用的文献

1
Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors.在小鼠乳腺上皮细胞中删除环氧化酶 2 通过增强肿瘤中的 1 型免疫应答来延迟乳腺癌的发生。
Carcinogenesis. 2011 Oct;32(10):1441-9. doi: 10.1093/carcin/bgr134. Epub 2011 Jul 18.
2
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
3
Phenotypical and functional specialization of FOXP3+ regulatory T cells.FOXP3+ 调节性 T 细胞的表型和功能特化。
Nat Rev Immunol. 2011 Feb;11(2):119-30. doi: 10.1038/nri2916.
4
Targeting Foxp3+ regulatory T cells-related immunosuppression for cancer immunotherapy.针对 Foxp3+ 调节性 T 细胞相关免疫抑制的癌症免疫治疗。
Chin Med J (Engl). 2010 Nov;123(22):3334-42.
5
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.每日服用阿司匹林对癌症导致的长期死亡风险的影响:来自随机试验的个体患者数据的分析。
Lancet. 2011 Jan 1;377(9759):31-41. doi: 10.1016/S0140-6736(10)62110-1. Epub 2010 Dec 6.
6
Prostaglandin E₂ regulates cellular migration via induction of vascular endothelial growth factor receptor-1 in HCA-7 human colon cancer cells.前列腺素 E₂ 通过诱导 HCA-7 人结肠癌细胞血管内皮生长因子受体-1 调节细胞迁移。
Biochem Pharmacol. 2011 Feb 1;81(3):379-87. doi: 10.1016/j.bcp.2010.11.001. Epub 2010 Nov 9.
7
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function.COX-2 抑制可改善免疫疗法,并与间皮瘤中髓样来源抑制细胞数量减少有关。塞来昔布影响 MDSC 功能。
BMC Cancer. 2010 Aug 30;10:464. doi: 10.1186/1471-2407-10-464.
8
IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia.IL-10 对巨噬细胞 VEGF 产生的调节依赖于巨噬细胞的极化和缺氧。
Immunobiology. 2010 Sep-Oct;215(9-10):796-803. doi: 10.1016/j.imbio.2010.05.025. Epub 2010 Jun 4.
9
The role of the microenvironment in mammary gland development and cancer.微环境在乳腺发育和癌症中的作用。
Cold Spring Harb Perspect Biol. 2010 Nov;2(11):a003244. doi: 10.1101/cshperspect.a003244. Epub 2010 Jun 30.
10
Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE₂ catabolism in myeloid cells.关键进展:通过改变髓系细胞内 PGE₂ 代谢,肿瘤诱导髓系来源的抑制细胞和 M2 极化的巨噬细胞。
J Leukoc Biol. 2010 Nov;88(5):839-48. doi: 10.1189/jlb.1209821. Epub 2010 Jun 29.